| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies (NCT00335998) | National Cancer Institute (NCI) | 2006-03-01 |
| Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers (NCT00856713) | Norgine | 2006-03-01 |
| Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function (NCT01507389) | Novo Nordisk A/S | 2006-03-01 |
| Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer (NCT00322400) | Amgen | 2006-03-01 |
| Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array (NCT00318318) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-03-01 |
| Intra Bone Marrow Injection Of Unrelated Cord Blood Cells (NCT00696046) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2006-03-01 |
| The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis (NCT00160004) | Radboud University Medical Center | 2006-03-01 |
| Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) (NCT00307229) | Ontario Clinical Oncology Group (OCOG) | 2006-03-01 |
| Kinetics of Etheric Oils, Smart Textiles vs. Ointment (NCT00299559) | Technische Universität Dresden | 2006-03-01 |
| Anti-Inflammatory Effect of Statins in the Human Endotoxin Model (NCT00309374) | Medical University of Vienna | 2006-03-01 |
| Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma (NCT00438802) | Mayo Clinic | 2006-03-01 |
| Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) (NCT01530048) | Novo Nordisk A/S | 2006-03-01 |
| Combined Modality Treatment for Patients With Stage IV Melanoma (NCT00313235) | Baylor Research Institute | 2006-03-01 |
| Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) (NCT00308269) | Endocyte | 2006-03-01 |
| Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver (NCT01146808) | Columbia University | 2006-03-01 |
| Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients (NCT00509938) | AM-Pharma | 2006-03-01 |
| Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy (NCT00428935) | Nationwide Children's Hospital | 2006-03-01 |
| Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer (NCT00291707) | University of Pittsburgh | 2006-03-01 |
| Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults (NCT00297687) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Trial Evaluating Safety, Tolerability and Immune Response of AG-707 (NCT00231049) | Agenus Inc. | 2006-03-01 |
| Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg (NCT00647959) | Mylan Pharmaceuticals Inc | 2006-03-01 |
| Botulin-A Toxin Instillations and Overactive Bladder (NCT00583219) | Mayo Clinic | 2006-03-01 |
| Renal Impairment in Type 2 Diabetic Subjects (NCT00554450) | AstraZeneca | 2006-03-01 |
| Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis (NCT00753987) | The Hospital for Sick Children | 2006-03-01 |
| Mycophenolate Mofetil in Systemic Sclerosis (NCT00433186) | Boston University | 2006-03-01 |
| Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan (NCT01367535) | Bausch Health Americas, Inc. | 2006-03-01 |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer (NCT00296062) | Case Comprehensive Cancer Center | 2006-03-01 |
| Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors (NCT00305084) | AGC Biologics S.p.A. | 2006-02-28 |
| Safety and Dose Study of Peramivir for Influenza Treatment (NCT00297050) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-23 |
| Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT00450944) | Albert Einstein College of Medicine | 2006-02-22 |
| Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects (NCT00331058) | GlaxoSmithKline | 2006-02-18 |
| Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers (NCT01034020) | National Institute on Drug Abuse (NIDA) | 2006-02-14 |
| Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer (NCT00325598) | Washington University School of Medicine | 2006-02-14 |
| Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients (NCT00527657) | M.D. Anderson Cancer Center | 2006-02-09 |
| Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT00305864) | National Cancer Institute (NCI) | 2006-02-09 |
| The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics (NCT00453791) | GlaxoSmithKline | 2006-02-07 |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00639639) | Gary Archer Ph.D. | 2006-02-06 |
| BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma (NCT00287495) | National Cancer Institute (NCI) | 2006-02-02 |
| Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma (NCT00398450) | University of California, San Diego | 2006-02-01 |
| Study Evaluating SKI-606 in Subject With Solid Tumors (NCT01001936) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects (NCT02211989) | Boehringer Ingelheim | 2006-02-01 |
| Allopurinol for Renal Transplant Associated Hypertension in Children (NCT00288171) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2006-02-01 |
| A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. (NCT00332215) | University of Minnesota | 2006-02-01 |
| Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children (NCT00260078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Cardiac Home Education and Support Trial (CHEST): A Pilot Study (NCT00275340) | University of Toronto | 2006-02-01 |
| Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells (NCT00275977) | Odense University Hospital | 2006-02-01 |
| Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients (NCT00406978) | Silvio Aime | 2006-02-01 |
| Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (NCT00634556) | Washington University School of Medicine | 2006-02-01 |
| Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma (NCT00291538) | Nantes University Hospital | 2006-02-01 |
| Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) (NCT00288431) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Taurine in Adolescents With Bipolar Disorder (NCT00391001) | Cambridge Health Alliance | 2006-02-01 |
| Endoscopic Bariatric Stapling Pilot Study (NCT01067625) | Satiety, Inc. | 2006-02-01 |
| Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 (NCT00519259) | National Institute on Drug Abuse (NIDA) | 2006-02-01 |
| A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer (NCT00421135) | Alaunos Therapeutics | 2006-02-01 |
| Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia (NCT00275080) | National Cancer Institute (NCI) | 2006-02-01 |
| Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL (NCT00344786) | Biogen | 2006-02-01 |
| Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy (NCT00293904) | Cytos Biotechnology AG | 2006-02-01 |
| Use of Oral Probiotics to Reduce Urinary Oxalate Excretion (NCT00587041) | Mayo Clinic | 2006-02-01 |
| Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS) (NCT00280631) | Telik | 2006-02-01 |
| Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors (NCT00345189) | Biogen | 2006-02-01 |
| Photobiomodulation as a New Approach for the Treatment of Nipple Traumas (NCT01462019) | Pontifícia Universidade Católica de Minas Gerais | 2006-02-01 |
| Micron Tracker: Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System (NCT00225446) | University Hospital, Grenoble | 2006-02-01 |
| A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation (NCT01478529) | Astellas Pharma Inc | 2006-02-01 |
| Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy (NCT00402415) | Yale University | 2006-02-01 |
| Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial (NCT00420134) | Shahid Beheshti University of Medical Sciences | 2006-02-01 |
| Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia (NCT00327054) | Aga Khan University | 2006-02-01 |
| Relative Bioavailability of Tipranavir (TPV)/Ritonavir (RTV) at Steady State Administered as Oral Solutions vs. Capsules in the Fed and Fasted State in Healthy Volunteers (NCT02227017) | Boehringer Ingelheim | 2006-02-01 |
| Protein and Energy Metabolism in Pediatric Crohn's Disease (NCT00583232) | Indiana University | 2006-02-01 |
| Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer (NCT00345761) | Chugai Pharmaceutical | 2006-02-01 |
| Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg (NCT00649636) | Mylan Pharmaceuticals Inc | 2006-02-01 |
| Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (NCT00294632) | M.D. Anderson Cancer Center | 2006-02-01 |
| A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers (NCT00337376) | Yale University | 2006-02-01 |
| Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy (NCT00786383) | Eli Lilly and Company | 2006-02-01 |
| Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis (NCT00294125) | University of Alabama at Birmingham | 2006-02-01 |
| Evaluating Patients With Impaired Hepatic Function (NCT00398424) | Taiho Oncology, Inc. | 2006-02-01 |
| Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery (NCT00289367) | Northwell Health | 2006-02-01 |
| Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients (NCT00359866) | Washington University School of Medicine | 2006-02-01 |
| Tolerability of Grazax-R in Children (NCT00298701) | ALK-Abelló A/S | 2006-02-01 |
| The Effect of High Dose Simvastatine on Multiple Myeloma (NCT00281476) | Vejle Hospital | 2006-02-01 |
| Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition (NCT01166087) | Dr. Reddy's Laboratories Limited | 2006-02-01 |
| Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors (NCT00708773) | University of Chicago | 2006-02-01 |
| Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer (NCT00331552) | University of Washington | 2006-02-01 |
| H5 Adult - Chiron Study of Bird Flu Vaccine (NCT00280033) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Study Evaluating IMA-638 in Asthma (NCT00339872) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-02-01 |
| Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction (NCT00387621) | Horng Chen | 2006-02-01 |
| Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy (NCT00486304) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain (NCT00287248) | Institute for Neurodegenerative Disorders | 2006-02-01 |
| A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects (NCT01514812) | Astellas Pharma Inc | 2006-02-01 |
| Study of Celecoxib Bioavailability in Healthy Subjects (NCT00296127) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-02-01 |
| Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions (NCT00834912) | Labopharm Inc. | 2006-02-01 |
| Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC (NCT00286793) | Ascenta Therapeutics | 2006-02-01 |
| Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen (NCT00286871) | Duke University | 2006-02-01 |
| Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant (NCT00354419) | Fred Hutchinson Cancer Center | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| Botox vs. Baclofen for Upper Limb Spasticity (NCT00280280) | Vanderbilt University | 2006-02-01 |
| Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases (NCT00469937) | Vanderbilt-Ingram Cancer Center | 2006-02-01 |
| Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (NCT00850057) | University of California, San Diego | 2006-02-01 |
| TY800 Dose Escalation (Typhoid) (NCT00269295) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) (NCT00311857) | Heidelberg University | 2006-02-01 |
| CVD 909 Vi Prime Boost Study (NCT00326443) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |